Clinical Trials Browser

Active not recruiting × Cystectomy × Genitourinary × Clear all

NCT03520491 2026-02-17

A Study to Test the Safety of Immunotherapy With Nivolumab Alone or With Ipilimumab Before Surgery for Bladder Cancer Patients Who Are Not Suitable for Chemotherapy

Phase 2 Active not recruiting

Urinary Bladder Neoplasms

NCT04960709 2025-12-19

VOLGA

Phase 3 Active not recruiting

Urinary Bladder Neoplasms

NCT05241340 2025-10-24

RAD-VACCINE

Phase 2 Active not recruiting

Urinary Bladder Diseases, Urinary Bladder Neoplasms, Urologic Diseases, Urologic Neoplasms

NCT03978624 2025-10-15

Window of Opportunity Study of Pembrolizumab Alone and in Combinations in Bladder Cancer

Phase 2 Active not recruiting

20 enrolled 11 charts

Urinary Bladder Neoplasms

NCT03924856 2025-08-28

KEYNOTE-866

Phase 3 Active not recruiting

Parkinson Disease 4, Autosomal Dominant Lewy Body, Urinary Bladder Neoplasms

NCT02968732 2025-07-04

Cystoscopic Evaluation Predicting pT0 Urothelial Carcinoma of the Bladder

Phase NA Active not recruiting

Carcinoma, Transitional Cell

NCT05776758 2025-04-16

Role of NAC in cT0 Muscle-invasive Bladder Cancer After Maximal TURBt

Phase 3 Active not recruiting

Urinary Bladder Neoplasms

NCT00938145 2025-04-11

3 Tesla MRI in Patients With Bladder Cancer

Phase NA Active not recruiting

Urinary Bladder Neoplasms

NCT04289779 2024-12-04

ABATE

Phase 2 Active not recruiting

Urinary Bladder Neoplasms